Alkylation of protein and DNA in mice treated with urethane

Carcinogenesis

Volumn 9, Issue 12, 1988, Pages 2197-2201

  Svensson, K ^a  

^a Department of Radiobiology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; RADIOISOTOPE; URETHAN;

ANIMAL EXPERIMENT; DNA ALKYLATION; EPOXYETHYL CARBAMATE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; MOUSE; NONHUMAN; SPLEEN; TESTIS;

ALKYLATION; ANIMAL; CARCINOGENS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBINS; MALE; MICE; MICE, INBRED CBA; PROTEINS; RISK; SUPPORT, NON-U.S. GOV'T; URETHANE; VINYL CHLORIDE;

EID: 0024245733     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/9.12.2197     Document Type: Article

References (45)

1. Ough, C. S. (1976) Ethylcarbamate in fermented beverages and foods. I. Naturally occurring ethylcarbamate. J. Agnc. Food Chem., 24, 323-327.
2. Lofroth, G. and Gejvall, T. (1971) Diethyl pyrocarbonate: formation of urethan in treated beverages. Science, 174, 1248-1250.
3. Schmeltz, I., Chiong, K. G. and Hoffmann, D. (1978) Formation and determination of ethyl carbamate in tobacco and tobacco smoke. J. Analyt. Toxicol, 2, 265-268.
4. Oehlkers, F. (1943) Die Auslosung von Chromosomen Mutationen in der Meiosis durch Einwirkung von Chemikalien. Z F. Vererbgsl., 81, 313-341.
5. Nettleship, A., Henshaw, P. S. and Meyer, H. L. (1943) Induction of pulmonary tumors in mice with ethyl carbamate (urethane). J. Natl. Cancer Inst., 4, 309-319.
6. Berenblum, I. (1982) Sequential aspects of chemical carcinogenesis: skin. In Becker, F.F. (ed.), Cancer. Plenum Press, New York, Vol. 1, 2nd edn., pp. 451-484.
7. IARC (1974) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol. 7. Some Antithyroid and Related Substances, Nitrofurans, and Industrial Chemicals. International Agency for Research on Cancer, Lyon, pp. 111-140.
8. Boyland, E. and Williams, K. (1969) Reactions of urethane with nucleic acids in vivo. Biochem. J., 111, 121-127.
9. 14C] ethyl carbamate (urethan). Carcinogenesis, 3, 539-546.
10. Scherer, E., Steward, E. P. and Emmelot, P. (1980) Formation of precancerous islands in rat liver and modification of DNA by ethyl carbamate: implications for its metabolism. In Holmstedt, B., Lauwerys.R., Mercier.M. and Roberfroid.M. (eds), Mechanisms of Toxicity and Hazard Evaluation. Elsevier/North Holland Biomedical Press, Amsterdam, pp. 249-254.
11. Scherer, E. and Emmelot, P. (1982) 7-(2-Oxoethyl)guanine, a possibly promutagenic base, in DNA modified in vivo by ethyl carbamate (urethane). Proceedings of the 13th International Cancer Congress, UICC, A550.
12. Osterman-Golkar, S. (1975) Studies on the reaction kinetics of biologically active electrophilic reagents as a basis, for risk estimates. Thesis, University of Stockholm, Stockholm, Sweden.
13. Osterman-Golkar, S., Ehrenberg, L., SegerbSck, D. and Hällström, I, (1976) Evaluation of genetic risks of alkylating agents II. Haemoglobin as a dose monitor. Mutat. Res., 34, 1-10.
14. Segerbäck, D. (1983) Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem.-Biol. Interactions, 45, 139-151.
15. Farmer, P. B., Gorf, S. M. and Bailey, E. (1982) Determination of hydroxy-propylhistidine in haemoglobin as a measure of exposure to propylene oxide using high resolution gas chromatography mass spectrometry. Biomed. Mass Spectrom., 9, 69-71.
16. Calleinan, C. J., Ehrenberg, L., Jansson, B., Osterman-Golkar, S., Segerback, D., Svensson, K. and Wachtmeister, C. A. (1978) Monitoring and risk assessement by means of alkyl groups in haemoglobin in persons occupationally exposed to ethylene oxide. J. Environ. Pathol. Toxicol., 2, 427-442.
17. Osterman-Golkar, S., Bailey, E., Farmer, P. B., Gorf, S. M. and Lamb, J. H. (1984) Monitoring exposure of propylene oxide through the determinalon of hemoglobin aJkylafion. Scand. J. Work Environ. Health., 10, 99-102.
18. Törnqvist, M., Mowrer, J., Jensen, S. and Ehrenberg, L. (1986) Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem., 54, 255-266.
19. Tomqvist, M., Osterman-Golkar, S., Kautiainen, A., Jensen, S., Farmer, P. B. and Ehrenberg, L. (1986) Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis, 7, 1519-1521.
20. Lawson, T. A. and Pound, A. W. (1973) The interaction of carbon-14-labelled alkyl carbamates, labelled in the alkyl and carbonyl positions, with DNA in vivo. Chem.-Biol. Interactions, 6, 99-105.
21. Zilkha, A. and Rappoport, S. (1963) Synthesis of hydroxyalkyl and mercaptoalkyl derivatives of sulfur-containing amino acids. J. Org. Chem., 28, 1105-1107.
22. Calleman, C. J. and Wachtmeister, C. A. (1979) Synthesis of N1-and NT-(2-hydroxyethyl)-L-histidines. Acta Chem. Scand., B33, 277-280.
23. Calleman, C. J. (1984) Hemoglobin as a dose monitor and its application to the risk estimation of ethylene oxide. Thesis, University of Stockholm, Stockholm, Sweden.
24. Ehrenberg, L., Hiesche, K. D., Osterman-Golkar, S. and Wennberg, I. (1974) Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat. Res., 24, 83-103.
25. Segerback, D., Calleman, C. J., Ehrenberg, L., Lofroth, G. and Osterman-Golkar, S. (1978) Evaluation of genetic risks of alkylating agents. IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after treatment of mice with methyl methanesulfonate. Mutat. Res., 49, 71-82.
26. Svensson, K. and Osterman-Golkar, S. (1986) Covalent binding of reactive intermediates to hemoglobin in the mouse as an approach to studying the metabolic pathways of 1,2-dichloroethane. In Singer, B. and Bartsch, H. (eds), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis. IARC Sci. Publ. No. 70, Lyon, pp. 269-279.
27. Svensson, K. and Osterman-Golkar, S. (1987) In vivo 2-oxoethyl adducts in hemoglobin and their possible origin. In Sandhu.S.S., DeMarini.D.M., Mass, MJ., Moore, M.M. and MumfordJ.S. (eds), Application of Short-Term Bioassays in the Analysis of Complex Environmental Mixtures V. Plenum Press, New York, pp. 49-66.
28. O’Flaherty, E. J. and Sichak, S. P. (1983) The kinetics of urethane elimination in the mouse. Toxicol. Appl. Pharmacol., 68, 354-358.
29. White, M. (1972) Studies of mechanism of induction of pulmonary adenomas in mice. In Le Cam.L.M. and Neyman.J. (eds), Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. University of California Press, Berkeley and Los Angeles, Vol. 4, pp. 287-307.
30. von Bahr, B., Ehrenberg, L., Scalia-Tomba, G. and Safwenberg, J. O. (1984) Study of different models for dose-response relationships (in Swedish), Appendix 9, Report to the Governmental Committee on Cancer Prevention. Ds S 1984:5, Stockholm.
31. Ehrenberg, L., Moustacchi, E. and Osterman-Golkar, S. (1983) Dosimetry of genotoxic agents and dose-response relationships of their effects. Mutat. Res., 123, 121-182.
32. Vesselinovitch, S. D. and Mihailovich, N. (1966) Significance of newborn age and dose of urethan in leukemogenesis. Cancer Res., 26, 1633-1637.
33. Schmahl, D., Port, R. and Wahrendorf, J. (1977) A dose-response study on urethane carcinogenesis in rats and mice. Int. J. Cancer, 19, 77-80.
34. Burstein, N. A., Mclntire, K. R. and Allison, A. C. (1970) Pulmonary tumours in germfree mice: induction with urethan. J. Natl. Cancer Inst., 44, 211-214.
35. Segerback, D. (1985) In vivo dosimetry of some alkylating agents as a basis for risk estimation. Thesis, University of Stockholm, Stockholm, Sweden.
36. Osterman-Golkar, S., Hultmark, D., SegerbSck, D., Calleman, C. J., Gothe, R., Ehrenberg, L. and Wachtmeister, C. A. (1977) Alkylation of DNA and proteins in mice exposed to vinyl chloride. Biochem. Biophys. Res. Comrnun., 76, 259-266.
37. Hussain, S. and Osterman-Golkar, S. (1976) Comment on the mutagenic effectiveness of vinyl chloride metabolites. Chem.-BioL Interactions, 12, 265-267.
38. Gotd, L. S., Sawyer, C. B., Magaw, R., Backman, G. M., de Veciana, M., Levinson, R., Hooper, N. K., Havender, W. R., Bernstein, L., Peto, R., Pike, M. C. and Ames, B. N. (1984) A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect., 58, 9-319.
39. Gehnng, P. J., Watanabe, P. G. and Park, C. N. (1978) Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example-vinyl chloride. Toxicol. Appl. Pharmacol., 44, 581-591.
40. Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G. and Caretti, D. (1981) Carcinogenicity bioassays of vinyl chloride monomer: a model of risk assessment of an experimental basis. Environ. Health Perspect., 41, 3-29.
41. 50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. Environ. Health Perspect., 58, 1-8.
42. Committee on the Evaluation of Carcinogenic Substances, National Health Council of The Netherlands, Swan, G.H.M., Department of Occupational Medicine, University of Limburg, Maastricht, The Netherlands.
43. 14C] vinyl chloride in the rat. Arch. Toxicol., 35, 153-162.
44. ICRP Publication 26 (1977) Recommendations of the International Commision on Radiological Protection. Ann. ICRP 1:3, Pergamon, Oxford.
45. 3H]sodium borohydride. In Singer, B. and Bartsch, H. (eds), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis. IARC Sci. Publ. No. 70, Lyon, pp. 109-125.